glp 1 agonist in pregnancy Maternal GLP-1 receptor activation inhibits fetal growth Reconciling GLP-1s and Pancreatitis

SUPPLEMENTAL DATA GRANTS This work was supported by NIH Grants R21HD112143 (to J.S.), R21HD111199 (to J.S.), R21HD107869 (to J.S.), DK095132 (to J.S.), and DK113007 (to J.S.)

Other oral compounds like CT-996 / RG 6652 showed a clinically meaningful weight reduction of 6-7% in four weeks among participants without T2D, and GSBR-1290 has demonstrated favourable safety, tolerability and efficacy results

Recent economic analyses have made this clearer

Sales of its obesity care products, including WEGOVY and SAXENDA, increased by 56% in Danish kroner and 57% at constant exchange rates (CER)

for example, 3 kg weight reduction leads to a marginal improvement in LDL-C and mean reduction in triglycerides of 15 mg/dL, while weight loss of 58 kg, lowers LDL-C on average by 5 mg/dL and increases HDL-C by 3 mg/dL